{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:21:39Z","timestamp":1762298499375},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cyto.2016.08.023","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T15:01:20Z","timestamp":1478098880000},"page":"107-114","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Role of Interleukin-22 in chronic liver injury"],"prefix":"10.1016","volume":"98","author":[{"given":"Rodrigo F.","family":"Carmo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria S.M.","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Moura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.cyto.2016.08.023_b0010","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0168-8278(99)80327-4","article-title":"Hepatic stellate cells and the regulation of liver inflammation","volume":"31","author":"Marra","year":"1999","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.cyto.2016.08.023_b0015","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.cyto.2016.08.023_b0020","first-page":"737","article-title":"Reversibility of liver fibrosis","volume":"9","author":"Brenner","year":"2013","journal-title":"Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.cyto.2016.08.023_b0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jhbp.245","article-title":"Recent advancement of molecular mechanisms of liver fibrosis","volume":"22","author":"Seki","year":"2015","journal-title":"J. Hepato-Biliary-Pancreatic Sci."},{"key":"10.1016\/j.cyto.2016.08.023_b0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: immunobiology and pathology","volume":"33","author":"Dudakov","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","article-title":"Biology of interleukin-22","volume":"32","author":"Wolk","year":"2010","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"12","key":"10.1016\/j.cyto.2016.08.023_b0045","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1128\/JVI.02943-12","article-title":"Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection","volume":"87","author":"Ivanov","year":"2013","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0050","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.ajpath.2012.12.007","article-title":"IL-22 is essential for lung epithelial repair following influenza infection","volume":"182","author":"Pociask","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.cyto.2016.08.023_b0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0060","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cyto.2016.08.023_b0065","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL\u201022) plays a protective role in T cell\u2010mediated murine hepatitis: IL\u201022 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0070","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2016.08.023_b0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jgh.12032","article-title":"Hepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver disease","volume":"28","author":"Kong","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0080","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.164.4.1814","article-title":"Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9","volume":"164","author":"Dumoutier","year":"2000","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2016.08.023_b0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/sj.gene.6363716","article-title":"IL-TIF\/IL-22: genomic organization and mapping of the human and mouse genes","volume":"1","author":"Dumoutier","year":"2000","journal-title":"Genes Immun."},{"issue":"40","key":"10.1016\/j.cyto.2016.08.023_b0090","doi-asserted-by":"crossref","first-page":"31335","DOI":"10.1074\/jbc.M005304200","article-title":"Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R","volume":"275","author":"Xie","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.cyto.2016.08.023_b0095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0969-2126(02)00797-9","article-title":"Crystal structure of recombinant human interleukin-22","volume":"10","author":"Nagem","year":"2002","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imr.12027","article-title":"IL-22, not simply a Th17 cytokine","volume":"252","author":"Rutz","year":"2013","journal-title":"Immunol. Rev."},{"issue":"20","key":"10.1016\/j.cyto.2016.08.023_b0105","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.febslet.2008.07.046","article-title":"Crystal structure of the IL-22\/IL-22R1 complex and its implications for the IL-22 signaling mechanism","volume":"582","author":"Bleicher","year":"2008","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.cyto.2016.08.023_b0110","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.str.2008.06.005","article-title":"Structure of IL-22 bound to its high-affinity IL-22R1 chain","volume":"16","author":"Jones","year":"2008","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jmb.2004.07.069","article-title":"The IL-10R2 binding hot spot on IL-22 is located on the N-terminal helix and is dependent on N-linked glycosylation","volume":"342","author":"Logsdon","year":"2004","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.cyto.2016.08.023_b0120","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1089\/10799900260442520","article-title":"Comparison of interleukin-22 and interleukin-10 soluble receptor complexes","volume":"22","author":"Logsdon","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.cyto.2016.08.023_b0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00011-014-0727-3","article-title":"Role of interleukin-22 in liver diseases","volume":"63","author":"Pan","year":"2014","journal-title":"Inflammation Res.: Off. J. Eur. Histamine Res. Soc."},{"issue":"37","key":"10.1016\/j.cyto.2016.08.023_b0135","doi-asserted-by":"crossref","first-page":"33676","DOI":"10.1074\/jbc.M204204200","article-title":"Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line Pathways that are shared with and distinct from IL-10","volume":"277","author":"Lejeune","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"48","key":"10.1016\/j.cyto.2016.08.023_b0140","doi-asserted-by":"crossref","first-page":"18177","DOI":"10.3748\/wjg.v20.i48.18177","article-title":"Role of interleukin-22 in inflammatory bowel disease","volume":"20","author":"Li","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.cyto.2016.08.023_b0145","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","article-title":"Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease","volume":"29","author":"Zenewicz","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0150","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10753-013-9715-y","article-title":"Targeting interleukin-22 in psoriasis","volume":"37","author":"Hao","year":"2014","journal-title":"Inflammation"},{"issue":"7","key":"10.1016\/j.cyto.2016.08.023_b0160","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3899\/jrheum.111027","article-title":"Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity","volume":"39","author":"da Rocha","year":"2012","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.cyto.2016.08.023_b0165","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/ard.2011.152074","article-title":"Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis","volume":"70","author":"Leipe","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.cyto.2016.08.023_b0170","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.4049\/jimmunol.178.9.5973","article-title":"IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn\u2019s disease","volume":"178","author":"Wolk","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2015.03.003","article-title":"Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C","volume":"158","author":"Wu","year":"2015","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0180","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.26916","article-title":"Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment","volume":"59","author":"Zhao","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cyto.2016.08.023_b0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.gene.6363786","article-title":"A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta","volume":"2","author":"Gruenberg","year":"2001","journal-title":"Genes Immun."},{"issue":"12","key":"10.1016\/j.cyto.2016.08.023_b0190","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.4049\/jimmunol.166.12.7096","article-title":"Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity","volume":"166","author":"Kotenko","year":"2001","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.cyto.2016.08.023_b0195","doi-asserted-by":"crossref","first-page":"9511","DOI":"10.1073\/pnas.171303198","article-title":"A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist","volume":"98","author":"Xu","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.cyto.2016.08.023_b0200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.gene.6364104","article-title":"Cloning of murine IL-22 receptor alpha 2 and comparison with its human counterpart","volume":"5","author":"Weiss","year":"2004","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/mi.2013.28","article-title":"Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid","volume":"7","author":"Martin","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"7423","key":"10.1016\/j.cyto.2016.08.023_b0210","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature11535","article-title":"IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine","volume":"491","author":"Huber","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.cyto.2016.08.023_b0215","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.4049\/jimmunol.0903416","article-title":"Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections","volume":"184","author":"Wilson","year":"2010","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.cyto.2016.08.023_b0220","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1073\/pnas.170291697","article-title":"Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor","volume":"97","author":"Dumoutier","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.cyto.2016.08.023_b0225","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.4049\/jimmunol.0904091","article-title":"IL-22 induces an acute-phase response","volume":"185","author":"Liang","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2016.08.023_b0230","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1053\/j.gastro.2011.06.051","article-title":"A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus","volume":"141","author":"Zhang","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0235","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","article-title":"In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression","volume":"54","author":"Park","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cyto.2016.08.023_b0240","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0245","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cyto.2011.07.022","article-title":"Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice","volume":"56","author":"Xing","year":"2011","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0250","first-page":"43","article-title":"Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3","volume":"1","author":"Pan","year":"2004","journal-title":"Cell. Mol. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0255","doi-asserted-by":"crossref","first-page":"G1019","DOI":"10.1152\/ajpgi.00239.2006","article-title":"IL-22-mediated liver cell regeneration is abrogated by SOCS-1\/3 overexpression in vitro","volume":"292","author":"Brand","year":"2007","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.cyto.2016.08.023_b0260","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3748\/wjg.v21.i5.1531","article-title":"Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines","volume":"21","author":"Lu","year":"2015","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0265","doi-asserted-by":"crossref","first-page":"G74","DOI":"10.1152\/ajpgi.00075.2009","article-title":"IL-22 is involved in liver regeneration after hepatectomy","volume":"298","author":"Ren","year":"2010","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"issue":"5","key":"10.1016\/j.cyto.2016.08.023_b0270","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/TP.0b013e3182449136","article-title":"IL-22: implications for liver ischemia\/reperfusion injury","volume":"93","author":"Chestovich","year":"2012","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.cyto.2016.08.023_b0275","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J","article-title":"Hepatitis B virus. The major etiology of hepatocellular carcinoma","volume":"61","author":"Beasley","year":"1988","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J. Viral Hepatitis"},{"issue":"9959","key":"10.1016\/j.cyto.2016.08.023_b0285","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.cyto.2016.08.023_b0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/icb.2011.79","article-title":"IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver","volume":"90","author":"Xiang","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0295","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.gastro.2012.03.044","article-title":"Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection","volume":"143","author":"Feng","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0300","first-page":"103","article-title":"Emerging role of Interleukin 22 in Hepatitis B virus infection: a double-edged sword","volume":"1","author":"Gao","year":"2013","journal-title":"J. Clin. Translational Hepatol."},{"issue":"s1","key":"10.1016\/j.cyto.2016.08.023_b0305","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00042737-200604000-00004","article-title":"Viral and host immune regulatory mechanisms in hepatitis C virus infection","volume":"18","author":"Mondelli","year":"2006","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0315","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2007.08.008","article-title":"Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes","volume":"48","author":"Zimmermann","year":"2008","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0320","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/cmi.2013.37","article-title":"The role of chemokines in acute and chronic hepatitis C infection","volume":"11","author":"Fahey","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2016.08.023_b0325","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cyto.2007.11.016","article-title":"The role of interleukin-22 in hepatitis C virus infection","volume":"41","author":"Dambacher","year":"2008","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.cyto.2016.08.023_b0330","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1478-3231.2007.01518.x","article-title":"Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection","volume":"27","author":"Hennig","year":"2007","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0335","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.27629","article-title":"IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections","volume":"61","author":"Sertorio","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0340","doi-asserted-by":"crossref","first-page":"e0154419","DOI":"10.1371\/journal.pone.0154419","article-title":"Pathological roles of Interleukin-22 in the development of recurrent Hepatitis C after liver transplantation","volume":"11","author":"Gao","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0345","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10620-011-1997-z","article-title":"Interleukin (IL)-17\/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection","volume":"57","author":"Foster","year":"2012","journal-title":"Dig. Dis. Sci."},{"issue":"9936","key":"10.1016\/j.cyto.2016.08.023_b0350","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0355","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1128\/CMR.00137-14","article-title":"Advances in the diagnosis of human schistosomiasis","volume":"28","author":"Weerakoon","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"issue":"11","key":"10.1016\/j.cyto.2016.08.023_b0360","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-3024.2009.01157.x","article-title":"Schistosomiasis and liver fibrosis","volume":"31","author":"Andrade","year":"2009","journal-title":"Parasite Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2016.08.023_b0365","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0370","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0375","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/hep.20400","article-title":"Interleukin 6 alleviates hepatic steatosis and ischemia\/reperfusion injury in mice with fatty liver disease","volume":"40","author":"Hong","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0300-483X(95)03128-3","article-title":"Recombinant human interleukin-6: safety issues of a pleiotropic growth factor","volume":"105","author":"Kamm\u00fcller","year":"1995","journal-title":"Toxicology"},{"issue":"7","key":"10.1016\/j.cyto.2016.08.023_b0385","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1271\/bbb.110061","article-title":"Interleukin-22 protects against acute alcohol-induced hepatotoxicity in mice","volume":"75","author":"Xing","year":"2011","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"12","key":"10.1016\/j.cyto.2016.08.023_b0390","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.cgh.2015.07.029","article-title":"Nonalcoholic fatty liver disease review: diagnosis, treatment, and outcomes","volume":"13","author":"Ahmed","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.cyto.2016.08.023_b0395","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0400","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1443-9573.2006.00237.x","article-title":"Pathogenesis of nonalcoholic steatohepatitis (NASH)","volume":"7","author":"Ma","year":"2006","journal-title":"Chin. J. Dig. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2016.08.023_b0405","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","article-title":"Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22","volume":"53","author":"Yang","year":"2010","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.cyto.2016.08.023_b0410","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cyto.2016.08.023_b0415","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.cyto.2016.08.023_b0420","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.4049\/jimmunol.1300016","article-title":"IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic","volume":"190","author":"Zenewicz","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0425","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ni.1684","article-title":"ROR\u03b3t and commensal microflora are required for the differentiation of mucosal interleukin 22\u2013producing NKp46+ cells","volume":"10","author":"Sanos","year":"2009","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-10-40","article-title":"Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)","volume":"10","author":"Poynard","year":"2010","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.cyto.2016.08.023_b0435","first-page":"369","article-title":"Emerging therapeutic targets for the treatment of hepatic fibrosis","author":"Fagone","year":"2015","journal-title":"Drug Discovery Today"},{"issue":"3","key":"10.1016\/j.cyto.2016.08.023_b0440","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hep.24486","article-title":"Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3","volume":"54","author":"Jiang","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cyto.2016.08.023_b0445","doi-asserted-by":"crossref","DOI":"10.1002\/hep.26528","article-title":"Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma","volume":"59","author":"Waidmann","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cyto.2016.08.023_b0450","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/ijc.29305","article-title":"Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma","volume":"136","author":"Zhao","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cyto.2016.08.023_b0455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cyto.2014.09.007","article-title":"IL-22, cell regeneration and autoimmunity","volume":"74","author":"Nikoopour","year":"2015","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.cyto.2016.08.023_b0460","doi-asserted-by":"crossref","first-page":"e93279","DOI":"10.1371\/journal.pone.0093279","article-title":"Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-\u03b3 responses","volume":"9","author":"Justa","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.cyto.2016.08.023_b0465","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1084\/jem.20092054","article-title":"Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A","volume":"207","author":"Sonnenberg","year":"2010","journal-title":"J. Exp. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661630477X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346661630477X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T01:51:59Z","timestamp":1536285119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346661630477X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":93,"alternative-id":["S104346661630477X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.08.023","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Interleukin-22 in chronic liver injury","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}